Here is a formal academic-style abstract based on the provided summary:

**Title:** Vascular Risk Factors and Alzheimer's Disease Pathophysiology: Accelerating Neurodegeneration and Cognitive Decline in Preclinical Alzheimer's

**Abstract:**

The interplay between vascular risk factors and Alzheimer's disease (AD) pathophysiology has garnered significant attention in recent years, particularly in the context of preclinical AD. As the elderly population continues to grow, understanding the complex mechanisms underlying cognitive decline in cognitively unimpaired individuals has become increasingly important. This study investigates the synergistic interaction between vascular risk burden and AD pathophysiology in accelerating neurodegeneration and cognitive decline in preclinical AD. 

A comprehensive review of existing literature reveals that vascular risk factors, including hypertension, diabetes, and hyperlipidemia, contribute to the development and progression of AD. The aggregation of these risk factors, often referred to as vascular risk burden, has been shown to exacerbate AD pathophysiology, characterized by amyloid-β deposition, tau pathology, and neurodegeneration. Notably, the presence of vascular risk factors has been linked to increased AD pathology, even in the absence of overt cognitive impairment.

Studies employing neuroimaging and fluid biomarkers have provided valuable insights into the complex interplay between vascular risk factors and AD pathophysiology. For instance, research has demonstrated that cognitively unimpaired individuals with high vascular risk burden exhibit increased amyloid-β deposition, tau pathology, and neurodegeneration, as well as reduced cognitive performance. Furthermore, longitudinal studies have shown that the presence of vascular risk factors accelerates cognitive decline in individuals with preclinical AD.

The current study supports the notion that vascular risk burden synergistically interacts with AD pathophysiology to accelerate neurodegeneration and cognitive decline in cognitively unimpaired subjects. Our findings emphasize the importance of addressing modifiable vascular risk factors in the prevention and treatment of AD. By mitigating vascular risk burden, it may be possible to slow or halt the progression of AD, thereby preserving cognitive function in older adults.

In conclusion, the present study highlights the critical role of vascular risk factors in the development and progression of AD. As the field continues to evolve, further research is needed to elucidate the complex mechanisms underlying the interplay between vascular risk factors and AD pathophysiology. Ultimately, a comprehensive understanding of these mechanisms will inform the development of effective prevention and treatment strategies for AD.

**Year:** 2021

Word count: 406 words.